OSR Health, Inc. (OSRHW) stock
Close on Oct 19, 2026Market cap $325.06KP/E –Yield –
OSR Health, Inc. saw revenue fall 50.2% to $1.81M over the twelve months to Jun 30, 2026. At the latest close the market valued the company at $325.06K.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $325.06K
- P/E ratio
- –
- Price to sales
- 0.18
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $1.81M
- EPS, diluted
- -$0.80
- Diluted shares
- 33M
Trading
- Previous close
- $0.01
- Open
- $0.01
- Day's range
- $0.01 – $0.01
- Volume
- 0
Market cap history
Month-end market cap since 2023, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | OSRHW | S&P 500 | Difference | OSRHW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -50.0% | +0.6% | −50.6 pts | ||
| 3 months | -75.8% | +3.4% | −79.2 pts | ||
| Year to date | -80.4% | +13.3% | −93.7 pts | ||
| 1 year | -74.8% | +16.6% | −91.4 pts |
Six years at a glance
Fiscal years 2020 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Press releases
Releases OSR Health filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Update
- Update
- Update
About OSR Health
Surgical & Medical Instruments & Apparatus
OSR Holdings, Inc. is a global healthcare holding company that acquires, builds, and operates healthcare-related businesses. Operating through three wholly owned subsidiaries under a hub-and-spoke model, the company focuses on developing oral T-cell immunotherapies for cancer treatment, creating design-augmented biologics for bone and cartilage regeneration as well as age-related degenerative diseases, and distributing neurovascular surgical devices and intervention systems in Korea. Its customers and end users include patients and healthcare providers requiring targeted interventions for oncology, degenerative disorders, and neurovascular procedures.
Company profile, executives and historyOSR Health stock: common questions
What is OSR Health's stock price?
OSRHW closed at $0.01 on Oct 19, 2026, up 0.00% on the day.
What is OSR Health's market cap?
OSR Health was worth $325.06K at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is OSRHW's P/E ratio?
OSR Health lost money over fiscal 2025 (diluted EPS -$0.80), so it has no meaningful P/E ratio.
How much revenue does OSR Health make?
OSR Health reported revenue of $1.81M for the twelve months to Jun 30, 2026, down 50.2% from a year earlier.
Does OSR Health pay a dividend?
No. OSR Health has not paid a cash dividend over the last twelve months.
How has OSRHW stock performed over the past year?
Including dividends, OSRHW returned -74.8% over the past year, against +16.6% for the S&P 500.
Who are OSR Health's competitors?
Companies most similar to OSR Health by business, industry and size include FEMY, RNXT, VYCO, ICU, HRGN.